Liontrust Investment Partners LLP has opened a new $303.3M position in $SPOT, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $SPOT.
$SPOT Hedge Fund Activity
We have seen 756 institutional investors add shares of $SPOT stock to their portfolio, and 544 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAILLIE GIFFORD & CO removed 1,210,072 shares (-11.2%) from their portfolio in Q2 2025, for an estimated $928,536,648
- FMR LLC added 1,001,188 shares (+19.7%) to their portfolio in Q2 2025, for an estimated $768,251,599
- LONE PINE CAPITAL LLC removed 913,564 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $502,487,606
- CAPITAL WORLD INVESTORS added 865,786 shares (+80.5%) to their portfolio in Q2 2025, for an estimated $664,352,229
- GQG PARTNERS LLC removed 736,300 shares (-90.7%) from their portfolio in Q2 2025, for an estimated $564,992,442
- GAMMA INVESTING LLC removed 716,307 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $549,651,013
- JPMORGAN CHASE & CO removed 716,275 shares (-12.0%) from their portfolio in Q2 2025, for an estimated $549,626,458
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SPOT Congressional Stock Trading
Members of Congress have traded $SPOT stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $SPOT stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 06/05.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 04/11 and 1 sale worth up to $100,000 on 05/12.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/20 and 1 sale worth up to $15,000 on 04/21.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 03/24, 02/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$SPOT Analyst Ratings
Wall Street analysts have issued reports on $SPOT in the last several months. We have seen 18 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 08/18/2025
- Keybanc issued a "Overweight" rating on 07/30/2025
- UBS issued a "Buy" rating on 07/30/2025
- Benchmark issued a "Buy" rating on 07/30/2025
- Morgan Stanley issued a "Overweight" rating on 07/30/2025
- Barclays issued a "Overweight" rating on 07/30/2025
- Wells Fargo issued a "Overweight" rating on 07/29/2025
To track analyst ratings and price targets for $SPOT, check out Quiver Quantitative's $SPOT forecast page.
$SPOT Price Targets
Multiple analysts have issued price targets for $SPOT recently. We have seen 24 analysts offer price targets for $SPOT in the last 6 months, with a median target of $775.0.
Here are some recent targets:
- Michael Morris from Guggenheim set a target price of $850.0 on 08/18/2025
- Jason Helfstein from Oppenheimer set a target price of $825.0 on 08/18/2025
- Mark Zgutowicz from Benchmark set a target price of $800.0 on 07/30/2025
- Kannan Venkateshwar from Barclays set a target price of $750.0 on 07/30/2025
- Manan Gosalia from Morgan Stanley set a target price of $800.0 on 07/30/2025
- Barton Crockett from Rosenblatt set a target price of $679.0 on 07/30/2025
- Justin Patterson from Keybanc set a target price of $830.0 on 07/30/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $SPOT ticker page for more data.
